Coherus Oncology CHRS Insider Ownership

NASDAQ CHRS
$0.99 -0.08 (-7.48%)
At close: Oct 16, 2026 · 4:00 PM EDT

Insider Holdings by Owner

1.67Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
1.23%
■0% pp QoQ
Shares Held by Insiders
1.91Mn
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
154.82Mn
154,816,912 shares
Direct Holdings
1.47Mn
Indirect: 432.68K
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
12
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

In the last 12 months, insiders at Coherus Oncology neither bought nor sold shares on the open market.

Form 4 Holdings

Insiders Holding CHRS

Insiders 12
Shares held 1.67Mn
Of outstanding 1.08%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Dennis M Lanfear President Ceo 1,048,235 0 1,048,235 62.9% 26 Jan, 2026
2 Bryan J Mcmichael Chief Financial Officer 133,736 0 133,736 8.0% 26 Jan, 2026
3 Vladimir Vexler Chief Scientific Officer 116,361 0 116,361 7.0% 04 Apr, 2023
4 Paul Reider Chief Commercial Officer 82,069 0 82,069 4.9% 22 Jan, 2025
5 Mcdavid Stilwell Chief Financial Officer 75,305 0 75,305 4.5% 03 Jan, 2024
6 Lee Nisley Newcomer Director 30,000 0 30,000 1.8% 09 Jun, 2026
7 Ali J. Satvat Director 30,000 0 30,000 1.8% 09 Jun, 2026
8 Charles W. Newton Director 30,000 0 30,000 1.8% 09 Jun, 2026
9 Jill O'Donnell-Tormey Director 30,000 0 30,000 1.8% 09 Jun, 2026
10 Rita A Karachun Director 30,000 0 30,000 1.8% 09 Jun, 2026
11 Mats Wahlstrom Director 30,000 0 30,000 1.8% 09 Jun, 2026
12 Michael Lee Ryan Director 30,000 0 30,000 1.8% 09 Jun, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

750 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
05 Jun, 2026 Jill O'Donnell-Tormey Director Acquired A 30,000 $0.00 $0 30,000 Direct
05 Jun, 2026 Lee Nisley Newcomer Director Acquired A 30,000 $0.00 $0 30,000 Direct
05 Jun, 2026 Charles W. Newton Director Acquired A 30,000 $0.00 $0 30,000 Direct
05 Jun, 2026 Ali J. Satvat Director Acquired A 30,000 $0.00 $0 30,000 Direct
05 Jun, 2026 Rita A Karachun Director Acquired A 30,000 $0.00 $0 30,000 Direct
05 Jun, 2026 Michael Lee Ryan Director Acquired A 30,000 $0.00 $0 30,000 Direct
05 Jun, 2026 Mats Wahlstrom Director Acquired A 30,000 $0.00 $0 30,000 Direct
05 Jun, 2026 Lee Nisley Newcomer Director Acquired A 60,000 $0.00 $0 60,000 Direct
05 Jun, 2026 Rita A Karachun Director Acquired A 60,000 $0.00 $0 60,000 Direct
05 Jun, 2026 Mats Wahlstrom Director Acquired A 60,000 $0.00 $0 60,000 Direct
05 Jun, 2026 Michael Lee Ryan Director Acquired A 60,000 $0.00 $0 60,000 Direct
05 Jun, 2026 Ali J. Satvat Director Acquired A 60,000 $0.00 $0 60,000 Direct
05 Jun, 2026 Jill O'Donnell-Tormey Director Acquired A 60,000 $0.00 $0 60,000 Direct
05 Jun, 2026 Charles W. Newton Director Acquired A 60,000 $0.00 $0 60,000 Direct
29 May, 2026 Dennis M Lanfear President Ceo Disposed D 200,000 — — 0 Direct
29 May, 2026 Bryan J Mcmichael Chief Financial Officer Disposed D 100,000 — — 0 Direct
29 May, 2026 Dennis M Lanfear President Ceo Disposed D 400,000 — — 0 Direct
29 May, 2026 Bryan J Mcmichael Chief Financial Officer Disposed D 25,000 — — 0 Direct
29 May, 2026 Bryan J Mcmichael Chief Financial Officer Disposed D 15,000 — — 0 Direct
29 May, 2026 Dennis M Lanfear President Ceo Disposed D 450,000 — — 0 Direct